Engineering Papers⌕ Search

SEARCH · Engineering Papers

Results for “TREAT”

Search indexed NASA NTRS and DOE OSTI research on propulsion, heat transfer, battery materials and energy systems. Follow report and document links to the original sources.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 73 records · Page 4

Reuse of Treated Internal or External Wastewaters in the Cooling Systems of Coal-Based Thermoelectric Power Plants

This study evaluated the feasibility of using three impaired waters - secondary treated municipal wastewater, passively treated abandoned mine drainage (AMD), and effluent from ash sedimentation ponds at power plants - for use as makeup water in recirculating cooling water systems at thermoelectric power plants. The evaluation included assessment of water availability based on proximity and relevant regulations as well as feasibility of managing cooling water quality with traditional chemical management schemes. Options for chemical treatment to prevent corrosion, scaling, and biofouling were identified through review of current practices, and were tested at bench and pilot-scale. Secondary treated wastewater is the most widely available impaired water that can serve as a reliable source of cooling water makeup. There are no federal regulations specifically related to impaired water reuse but a number of states have introduced regulations with primary focus on water aerosol 'drift' emitted from cooling towers, which has the potential to contain elevated concentrations of chemicals and microorganisms and may pose health risk to the public. It was determined that corrosion, scaling, and biofouling can be controlled adequately in cooling systems using secondary treated municipal wastewater at 4-6 cycles of concentration. The high concentration of dissolved solids in treated AMD rendered difficulties in scaling inhibition and requires more comprehensive pretreatment and scaling controls. Addition of appropriate chemicals can adequately control corrosion, scaling and biological growth in ash transport water, which typically has the best water quality among the three waters evaluated in this study. The high TDS in the blowdown from pilot-scale testing units with both passively treated mine drainage and secondary treated municipal wastewater and the high sulfate concentration in the mine drainage blowdown water were identified as the main challenges for blowdown disposal. Membrane treatment (nanofiltration or reverse osmosis) can be employed to reduce TDS and sulfate concentrations to acceptable levels for reuse of the blowdown in the cooling systems as makeup water.

01 COAL, LIGNITE, AND PEAT↗

Role of carbon treating in piperazine oxidation

Bench-scale experiments were performed to test the effects of carbon treating (8 × 30 mesh, lignite-based granular activated carbon from Nowata Filtration) on the oxidation of aqueous piperazine (PZ) at conditions of CO 2 capture. The combined mitigation with carbon treating and N 2 sparging was also tested. When carbon treating is applied, the UV–Vis absorbance at 320 nm, the NH 3 production rate, and the accumulation rate of dissolved Fe concentration and total formate concentration decrease. The effects of carbon treating last even when the carbon is bypassed, which is possibly due to the removal of catalytic degradation products. Therefore, it is better to apply carbon treating in the early stages of oxidation. Combining carbon treating and nitrogen sparging is more effective in oxidation mitigation than applying the methods separately. The amount of Fe removed by the carbon bed is greater than the result calculated from the solvent inventory and concentration difference of Fe in solvent, indicating that Fe colloids or other “soluble” Fe will dissolve into the solvent and replace the dissolved Fe that is adsorbed and removed. Furthermore, the carbon removes the degradation products that can complex with Fe 3+ , even if they are not complexed. Since the source of Fe includes fly ash and corrosion, removing the complexing agents instead of all the available Fe is a more feasible target.

37 INORGANIC, ORGANIC, PHYSICAL, AND ANALYTICAL CH↗

Analyses Supporting Design Review of TREAT Multi-SERTTA Experiment Test Vehicle

The Transient Test Reactor (TREAT) Facility was designed to evaluate nuclear fuels and structural materials under simulated nuclear excursion and transient power/cooling mismatch situations that could be encountered in nuclear reactors [1]. It was historically operated from 1959 through 1994; ongoing activities at Idaho National Laboratory (INL) include resumption of transient testing capabilities to generate experimental data suitable to validate advanced modeling and simulation of these transient conditions, supporting current and next generation power reactor design and nuclear safety [2]. The resumption of transient testing requires new experiment vehicle designs to satisfy testing needs. The most developed experiment test vehicle candidate in TREAT’s arsenal will be the Multi-SERTTA (Static Environment Rodlet Transient Test Apparatuses) [3], which accommodates up to four concurrent rodlets under separate environmental conditions. An overview of the Multi-SERTTA, which would be placed at the center of the TREAT core during use, is shown in Figure 1. In the current design, all four rodlet test vessels are identical except for flux shaping collar material content to meet design needs. As the date rapidly approaches for TREAT restart, there is a need to have the Multi-SERTTA design approved and tested. Test experiments are an integral component of TREAT operations, and will be integrated among initial restart testing and supporting core reactor physics measurements. An integral step in finalization of any test vehicle design for TREAT is the hosting and resolution of a formal design review.

21 SPECIFIC NUCLEAR REACTORS AND ASSOCIATED PLANTS↗

FY19 Transient Prescriptions in TREAT Full-Slotted Core

The transient reactor test facility (TREAT) is a graphite-based transient test reactor at the Idaho National Laboratory. TREAT started operation in 1959 and performed thousands of transient irradiations for the primary purpose of nuclear fuel safety research. TREAT operations were suspended in 1994 and then, several years later, resumed reactor operations in 2017 to support development of advanced nuclear fuels. During TREAT’s first era of operation the transient rod drive system and eventual Automatic Reactor Control System (ARCS) were upgraded and improved to create a transient reactor capable of unparalleled power shaping capabilities. TREAT’s first year of modern experiment work was performed in 2018 and saw the demonstration of new kinds of transients focused on modern experiment needs; especially focused on light water reactor (LWR) category transients including reactivity-initiated accidents (RIA) and loss of coolant accidents (LOCA). These transients were performed using a non-fueled neutronic mockup of a historical sodium loop which was not a perfect representation of future core configurations, but was adequate for demonstrating capabilities, successfully troubleshooting transient programming parameters, and calibrating nuclear models of the core. These physics tests were termed “transient prescription tests”. Later in 2018 the core was reconfigured to a modern fueled experiment arrangement and TREAT began performing irradiations on LWR rodlets where crucial fuel specimen nuclear heating data were obtained, and several supporting systems were commissioned. This successful effort gave way to additional fueled experiments which were performed throughout 2019.

11 NUCLEAR FUEL CYCLE AND FUEL MATERIALS↗

Surrogate Models for TREAT Transient Calculations

The Transient Reactor Test Facility (TREAT) at Idaho National Laboratory (INL) is currently preparing for resumption of operation after more than 20 years in a long-term standby state. In parallel with preparation for operations and a new transient testing program, the DOE-NE Advanced Modeling and Simulation program (NEAMS) has been supporting the development of three-dimensional transient multi-physics modeling capabilities within the reactor physics application MAMMOTH [1]. Recently, the MAMMOTH reactor physics team has begun development of uncertainty and sensitivity analysis for the TREAT core. This research will be used to support the analysis of reactor operation and experiment planning. Traditional approaches, i.e., Monte Carlo simulations, for such tasks require a large number of model evaluations under both steady state and transient conditions. However, exhaustive sets of sampling runs are simply not practical here since evaluations of each model can take a substantial amount of time. A solution to this problem is to build a surrogate model employing a smaller number of model evaluations. The surrogate model is designed to provide an accurate and fast approximation to the detailed TREAT model. In this manner, the surrogate model can be used in place of the TREAT transient model for uncertainty and sensitivity analysis at a fraction of the computational cost. The high dimensional model representation (HDMR) [2] method is employed here for approximating the responses of interest in terms of functions of lower dimensions. This method has been implemented in RAVEN [3] and all TREAT transient calculations are performed using the multiphysics code MAMMOTH. In addition, a code interface has also been developed in order to couple RAVEN with MAMMOTH. The surrogate model is then tested and compared for the MAMMOTH model of the TREAT startup testing program Transient Test #15 core [4], and its accuracy is measured by its ability to estimate the mean, coefficient of variance, skewness, excess kurtosis and probability density function of the outputs of Transient Test #15 model, as well as root mean square error metric.

22 GENERAL STUDIES OF NUCLEAR REACTORS↗

Capabilities development for transient testing of advanced nuclear fuels at TREAT

The TREAT facility is a unique capability at the Idaho National Laboratory currently being prepared for resumption of nuclear transient testing. TREAT is an air-cooled reactor where the driver core is made up of urania dispersed in graphite blocks and encapsulated in zirconium alloy cans. In addition to the reactor itself, the foundation for TREAT's capabilities will also include a suite of irradiation vehicles and supporting infrastructure to provide the desired specimen boundary conditions while supporting a variety of instrumentation needs. Although TREAT historically supported all kinds of nuclear fuels, including LWR's, SFR's, space nuclear propulsion, research reactor plate-type fuels, and even fuels for use in the driver core of other transient test reactors, the majority of TREAT's more-recent experiment programs revolved around SFR's and sodium-environment test capsules and loops. MK-series loop experiment-specific test trains could be outfitted with a variety of instruments to monitor test and specimen conditions while the fast neutron hodoscope collected information about fuel movement before, during, and after transient excursions. The SERTTA (Static Environment Rodlet Transient Test Apparatuses) devices will be general purpose vehicles capable of providing inert gas, water (up to PWR conditions), steam, or perhaps even molten sodium environments within vessel-like capsules. The Multi-SERTTA vehicle design is particularly novel as it makes use of the full active core length in TREAT to test four small rodlets (∼12 cm length), each within its own hermetic boundary, it will be capable of housing pre-irradiated fuel specimens. Additional modules and adaptations of Multi-SERTTA will enable rapid loop pressure blowdown to simulate LOCA conditions. The Super-SERTTA, akin to the Multi-SERTTA will offer more possibilities for simulating transient phenomena.

21 SPECIFIC NUCLEAR REACTORS AND ASSOCIATED PLANTS↗

Testing of graphite thermal neutron scattering law data in support of treat neutronic analysis

The Transient Reactor Test Facility (TREAT) has historically provided the capability for transient fuel performance and safety testing in the United States. The operation of this facility was suspended in 1994. However, in recent years preparations for the restart of TREAT were initiated. TREAT is a graphite moderated and air cooled reactor. Its core is composed of a 19 x 19 array of fuel assemblies that contain UO{sub 2} (HEU) fuel particles dispersed in a graphite matrix, along with reflector assemblies filled with graphite only. Each fuel assembly is 8 feet tall with a fueled region that is 4 feet tall and upper and lower regions of graphite that are 2 feet tall. In addition, a 2 feet thick radial graphite reflector region is present. Finally, a 5 feet thick concrete biological shield surrounds the core. Previous work showed that the graphite thermal scattering cross sections can introduce variations exceeding 2000 pcm in the predicted eigenvalue of the TREAT core. Recognizing that the graphite in the assembly (and thereby the core) is a porous mixture of crystalline and amorphous carbon (with a lower density in comparison to ideal crystalline graphite), it becomes clear that TREAT specific thermal neutron scattering cross section libraries will be needed (at all temperatures of interest) for use within neutronic codes seeking to simulate TREAT. (authors)

21 SPECIFIC NUCLEAR REACTORS AND ASSOCIATED PLANTS↗

Conceptual Phase Neutronic and Thermal Analyses for the LEU Conversion of the Transient Reactor Test Facility (TREAT)

The Transient Reactor Test Facility (TREAT) is an experimental reactor designed for transient testing of nuclear reactor fuels and other materials. TREAT is located at the Idaho National Laboratory (INL). It was operated from 1959 until 1994, when it was placed on nonoperational standby. Preparations for the restart of TREAT are now underway. Simultaneously, work is being performed to support the conversion of TREAT from its current high enriched uranium (HEU) fuel to low enriched uranium (LEU, defined as uranium with less than 20% {sup 235}U) fuel, under the support of the Department of Energy (DOE) National Nuclear Security Administration (NNSA) Material Management and Minimization (M{sup 3}) reactor conversion program. Following the pre-conceptual phase of the TREAT conversion project (which included assessments of conversion feasibility, including LEU fuel element fabrication feasibility), conceptual phase work was performed to evaluate potential LEU fuel element designs for TREAT. Simultaneously, activities including scale-up development work for fuel fabrication and mock-up element production were performed by the INL Fuel Engineering and Design (FED) team. Utilizing the lessons learned in the analysis and fabrication work, an LEU conceptual design description was collaboratively established and evaluated in detail. A summary of this work and corresponding example results are presented here. (authors)

21 SPECIFIC NUCLEAR REACTORS AND ASSOCIATED PLANTS↗

Cardiac Mortality in Patients With Stage I and II Diffuse Large B-Cell Lymphoma Treated With and Without Radiation: A Surveillance, Epidemiology, and End-Results Analysis

Purpose: Standard therapy for stage I and II diffuse large B-cell lymphoma consists of combined modality therapy with anthracycline-based chemotherapy, anti-CD20 antibody, and radiation therapy (RT). Curative approaches without RT typically utilize more intensive and/or protracted chemotherapy schedules. Anthracycline-based chemotherapy regimens are associated with a dose-dependent risk of left ventricular systolic dysfunction. We hypothesize that patients treated without RT, i.e., those who are treated with greater total chemotherapy cycles and hence cumulative anthracycline exposure, are at increased risk of cardiac mortality. Methods and Materials: The rate of cardiac-specific mortality (CSM) was analyzed in patients with stage I and II diffuse large B-cell lymphoma diagnosed between 1988 and 2004 by querying the National Cancer Institute Surveillance, Epidemiology, and End-Results database. Analyzable data included gender, age, race, stage, presence of extranodal disease, and RT administration. Results: A total of 15,454 patients met selection criteria; 6,021 (39%) patients received RT. The median follow-up was 36 months (range, 6-180 months). The median age was 64 years. The actuarial incidence rates of CSM at 5, 10, and 15 years were 4.3%, 9.0%, and 13.8%, respectively, in patients treated with RT vs. 5.9%, 10.8% and 16.1%, respectively, in patients treated without RT (p < 0.0001; hazard ratio, 1.35; 95% confidence interval [CI]: 1.16-1.56). The increase in cardiac deaths for patients treated without RT persisted throughout the follow-up period. On multivariate analysis, treatment without RT remained independently associated with an increased risk of CSM (Cox hazard ratio, 1.32; 95% CI: 1.13-1.54; p = 0.0005). Conclusions: Increased anthracycline exposure in patients treated only with chemotherapy regimens may result in an increase in cardiac deaths, detectable only through analysis of large sample sizes. Confirmatory evaluation through meta-analysis of randomized data and design of large prospective trials is warranted.

62 RADIOLOGY AND NUCLEAR MEDICINE↗

Population-Based Study of Cardiovascular Mortality Among Patients With Prostate Cancer Treated With Radical External Beam Radiation Therapy With and Without Adjuvant Androgen Deprivation Therapy at the British Columbia Cancer Agency

Purpose: There are conflicting studies of the impact of androgen deprivation therapy (ADT) on cardiovascular (CV) mortality among prostate cancer patients receiving curative intent external beam radiation therapy (EBRT). We assessed the impact of ADT on CV mortality in patients treated in British Columbia. Methods and Materials: Provincial pharmacy and radiotherapy databases were linked to the provincial cancer registry, and defined a cohort of patients treated with curative intent EBRT between 1998 and 2005. We determined the duration of ADT and the cumulative incidence of CV death. We compared death from CV disease with and without ADT, and by duration of ADT using competing risk analysis and Fine and Gray multivariant analysis. A total of 600 randomly selected patients were reviewed to determine baseline CV disease, CV risk factors, and Charlson Index. Results: Of 5,948 prostate cancer patients treated with radical intent EBRT, of whom 1,933 were treated without ADT, 674 received ADT for {<=}6 months and 3,341 received > 6 months of ADT. The cumulative CV mortality at 7 years was 2.6% (95% confidence interval [CI] 1.9-3.5%), 2.1% (95% CI = 1.2-3.5%), and 1.4 (95% CI = 1.0-2.0%) for patients with no ADT, {<=}6 months of ADT, and >6 months of ADT, respectively (Gray's p = 0.002). Baseline CV disease and risk factors were more prevalent in the no-ADT group compared with the >6-month ADT group. Conclusions: This study demonstrated a lower CV mortality rate among patients treated with longer durations of ADT than those treated without ADT. These differences likely relate to selection of patients for ADT rather than effect of ADT itself.

62 RADIOLOGY AND NUCLEAR MEDICINE↗

Outcome of Patients Treated With a Single-Fraction Dose of Palliative Radiation for Cutaneous T-Cell Lymphoma

Purpose: Cutaneous T-cell lymphoma (CTCL) is a radiosensitive tumor. Presently, treatment with radiation is given in multiple fractions. The current literature lacks data that support single-fraction treatment for CTCL. This retrospective review assesses the clinical response in patients treated with a single fraction of radiation. Methods and Materials: This study reviewed the records of 58 patients with CTCL, primarily mycosis fungoides, treated with a single fraction of palliative radiation therapy (RT) between October 1991 and January 2011. Patient and tumor characteristics were reviewed. Response rates were compared using Fisher's exact test and multiple logistic regressions. Survival rates were determined using the Kaplan-Meier method. Cost-effectiveness analysis was performed to assess the cost of a single vs a multifractionated treatment regimen. Results: Two hundred seventy individual lesions were treated, with the majority (97%) treated with ≥700 cGy; mean follow-up was 41.3 months (range, 3-180 months). Response rate by lesion was assessed, with a complete response (CR) in 255 (94.4%) lesions, a partial response in 10 (3.7%) lesions, a partial response converted to a CR after a second treatment in 4 (1.5%) lesions, and no response in 1 (0.4%) lesion. The CR in lower extremity lesions was lower than in other sites (P=.0016). Lesions treated with photons had lower CR than those treated with electrons (P=.017). Patients with lesions exhibiting large cell transformation and tumor morphology had lower CR (P=.04 and P=.035, respectively). Immunophenotype did not impact response rate (P=.23). Overall survival was significantly lower for patients with Sézary syndrome (P=.0003) and erythroderma (P<.0001). The cost of multifractionated radiation was >200% higher than that for single-fraction radiation. Conclusions: A single fraction of 700 cGy-800 cGy provides excellent palliation for CTCL lesions and is cost effective and convenient for the patient.

62 RADIOLOGY AND NUCLEAR MEDICINE↗

Surgical Resection of Brain Metastases and the Risk of Leptomeningeal Recurrence in Patients Treated With Stereotactic Radiosurgery

Purpose: Recent prospective data have shown that patients with solitary or oligometastatic disease to the brain may be treated with upfront stereotactic radiosurgery (SRS) with deferral of whole-brain radiation therapy (WBRT). This has been extrapolated to the treatment of patients with resected lesions. The aim of this study was to assess the risk of leptomeningeal disease (LMD) in patients treated with SRS to the postsurgical resection cavity for brain metastases compared with patients treated with SRS to intact metastases. Methods and Materials: Four hundred sixty-five patients treated with SRS without upfront WBRT at a single institution were identified; 330 of these with at least 3 months' follow-up were included in this analysis. One hundred twelve patients had undergone surgical resection of at least 1 lesion before SRS compared with 218 treated for intact metastases. Time to LMD and overall survival (OS) time were estimated from date of radiosurgery, and LMD was analyzed by the use of cumulative incidence method with death as a competing risk. Univariate and multivariate analyses were performed with competing risk regression to determine whether various clinical factors predicted for LMD. Results: With a median follow-up time of 9.0 months, 39 patients (12%) experienced LMD at a median of 6.0 months after SRS. At 1 year, the cumulative incidence of LMD, with death as a competing risk, was 5.2% for the patients without surgical resection versus 16.9% for those treated with surgery (Gray test, P<.01). On multivariate analysis, prior surgical resection (P<.01) and breast cancer primary (P=.03) were significant predictors of LMD development. The median OS times for patients undergoing surgery compared with SRS alone were 12.9 and 10.6 months, respectively (log-rank P=.06). Conclusions: In patients undergoing SRS with deferral of upfront WBRT for intracranial metastatic disease, prior surgical resection and breast cancer primary are associated with an increased risk for the development of LMD.

62 RADIOLOGY AND NUCLEAR MEDICINE↗

The study of aluminum loss and consequent phase transformation in heat-treated acid-leached kaolin

This study investigates the effect of Al leaching during Fe removal from kaolin to mullite. Heat-treated kaolin was obtained by heating natural kaolin at 400, 500, 600, 700, 800 and 900 deg. C. The heat-treated kaolin was then leached at 100 deg. C with 4 M, 3 M, 2 M, 1 M, 0.2 M solution of H{sub 2}SO{sub 4} and 0.2 M solution of oxalic acid. The dried samples were sintered to 1300 deg. C for 4 h at a heating rate of 10 deg. C min{sup -1}. X-ray diffractometry and differential thermal analysis were used to study the phase transformation of kaolin to mullite. It was found that 700 deg. C is the optimum preheat-treatment temperature to leach out Fe and also Al for both types of the acids used. The majority of the 4 M sulfuric acid-treated kaolins formed the cristobalite phase when sintered. On the other hand, 1 M, 0.2 M sulfuric acid and 0.2 M oxalic acid leached heat-treated kaolin formed mullite and quartz phase after sintering. - Research Highlights: {yields} Preheat-treatment of kaolin improves the leachability of unwanted iron. {yields} The optimum preheat-treatment temperature is 700 deg. C. {yields} Sintered 4 M sulfuric acid-treated kaolin majorly formed the cristobalite phase. {yields} Sintered 0.2 M oxalic acid-treated kaolin formed lesser amorphous silicate phase.

36 MATERIALS SCIENCE↗

Mechanical behavior and texture development of over-aged and solution treated Al-Cu-Mg alloy during multi-directional forging

The effects of initial heat treatments, i.e. solution treating and over ageing, on deformation behavior of an age hardenable Al-Cu-Mg alloy, including mechanical properties and texture evolution, during multi-directional forging (MDF) are investigated. Hardness measurements, electron back scatter diffraction (EBSD) maps, and differential scanning calorimetry (DSC) are carried out. Mechanical behaviors of the alloy in terms of compressive stress and hardness test after MDF are investigated. In both solution treated and over-aged alloys, the compressive stress during MDF shows an increase up to the second pass, and by further straining the flow stress is decreased. However, shear and deformation bands are formed in both solution treated and over-aged alloys, the density of these instabilities in the solution treated alloy is higher than that in over-aged alloy. In the solution treated alloy, not only large particles induce deformation bands, but also the dynamically formed GPB zones/Cu-Mg co-clusters. Texture analysis shows that the shear component of C {001}<110> (Φ{sub 1} = 90°, Φ = 0°, Φ{sub 2} = 45°) is developed with 18 mrd during MDF of the over-aged alloy. In the solution treated alloy, due to the high density of deformation bands and different microchemistry of the matrix in comparison with that of the over-aged alloy, the Copper type texture component {112}<111> (Φ{sub 1} = 90°, Φ = 35°, Φ{sub 2} = 45°) is developed with 11 mrd.

36 MATERIALS SCIENCE↗

Suitability of Type-II Fiber Bragg Gratings in Silica Optical Fiber for Temperature Sensing in TREAT

Optical fibers provide a variety of options for instrumentation in reactor environments. Optical fibers can be used to measure multiple physical phenomena including, temperature, strain, pressure, and fluid level. In addition to the various sensing applications, optical fibers are immune to electromagnetic interference, have a small footprint (~100 μm), and a fast response. The Department of Energy and Idaho National Laboratory have considered optical fibers for use as in-pile instrumentation in the Transient Reactor Test Facility (TREAT). TREAT was designed to test reactor fuels under accident conditions by replicating accident conditions for a variety of reactor transients, such as those associated with a loss of coolant accident (LOCA). This work investigates silica fiber optic temperature sensors with inscribed type-II fiber Bragg gratings (FBGs) under conditions similar to those that would be experienced in a TREAT transient. Separate effects testing was used to test the sensors under high-temperature step transients and under irradiation up to a total fluence similar to that of TREAT. Specifically, this work investigates distributed temperature measurements, using the Optical Frequency Domain Reflectometry (OFDR) sensing technique, using a Luna Innovations Optical Backscatter Reflectometer (OBR) 4600, with silica optical fibers inscribed with type-II fiber Bragg gratings (FBGs). In conclusion, separate effects testing of type-II FBGs in silica optical fiber, to high temperature and to neutron fluences that are an order of magnitude larger than fluences that are anticipated for TREAT tests, demonstrate that type-II FBGs in silica optical fiber hold great promise for high-temperature reactor instrumentation in TREAT.

McCary, Kelly↗

Uranium Ion Exchange Resin Performance - A Case Study at 200 West Pump and Treat - 18103

The 200 West Pump and Treat Facility (200W P and T), located on the U.S. Department of Energy's Hanford site, is a 2,500 gallon per minute (GPM) plant designed to capture and treat an eight square kilometer groundwater plume. The groundwater contamination is largely a result of process liquids disposed from operations involving the separation of nuclear materials and storage of spent nuclear fuel. This document will report on the performance of a full scale uranium ion exchange system used to treat contaminated groundwater and other waste streams. The uranium ion exchange system at 200W P and T was designed as a three vessel operation with a lead, lag and polish vessel, which contain 300 cubic feet of resin in each vessel. The ion exchange system treats a portion of the total plant flow with a maximum capacity of 400 GPM. Prior to start-up, one key issue was the potential to treat feed streams with a wide range of uranium concentrations (22 to 150,000 microgram per liter [μg/L]). The resin change-out frequency was a primary concern. A literature review was performed, resulting in resin capacity and change out frequency that varied by two orders of magnitude (1.2 milligram per gram [mg/g] to 104 mg/g capacity). Since startup in September 2015, the ion exchange system has experienced a dynamic feed stream as wells were brought online, which changed the contaminant concentrations. The plant also treats leachate liquid waste from on-site low-level waste site, known as the Environmental Restoration Disposal Facility (ERDF), which contains uranium as well as other competing anions, such as sulfate. The uranium breakthrough is closely monitored throughout the resin beds with weekly sampling events at the influent, effluent, and intermediate ports in the first vessel. In the influent to the ion exchange system, the uranium concentration fluctuated from 24 μg/L up to 910 μg/L. The information on influent and effluent was used to determine the change out frequency and the capacity of the resin for uranium under these operating conditions. (authors)

12 MANAGEMENT OF RADIOACTIVE AND NON-RADIOACTIVE W↗

Baseline Radiological Conditions for the Transient Reactor Test (TREAT) Restart

The Transient Reactor Test (TREAT) facility, located on the Idaho National Laboratory (INL), northwest of the Materials and Fuels Complex (MFC), has been in programmatic shutdown for more than twenty-three years. Construction of TREAT by the Teller Construction Co., Portland, Oregon, was started in February, 1958, and completed in early November, 1958. The reactor first achieved criticality on February 23, 1959. Operations continued until April 28, 1994, when the reactor was shut down due to the lack of a programmatic mission. Recently, the U.S. Department of Energy (DOE) identified a need to resume transient testing of new reactor fuels. The Resumption of Transient Testing Program (RTTP) has readied the TREAT facility to resume transient testing operations. The first reactor criticality since the shut down in 1994 was achieved on November 14, 2017. This report details the radiological measurements taken in the TREAT Reactor Building and the surrounding environment prior to and just after its restart in order to characterize the radiological conditions that existed prior to and during the initial restart operations. The authors would like to acknowledge the support from RTTP Management and the TREAT Operations staff for allowing the extensive radiological surveys, as well as the health physics technicians from the INL Radiological Control organization who performed many of the measurements referenced in this report.

21 SPECIFIC NUCLEAR REACTORS AND ASSOCIATED PLANTS↗

Initial validation of ALFRED: A Monte Carlo code built on Geant4 for TREAT energy deposition

Predicting the energy deposited in the specimen during an experiment in the Transient Reactor Test (TREAT) Facility is a complex problem due to the nature of the transients occurring in the reactor. In addition, the many particles contributing to energy deposition have different behavior in time and space. ALFRED, a new Geant4 based code, is developed to transport and simulate each particle generated in the core. This code is verified against OpenMC (Open Monte Carlo) on the Godiva benchmark and a simple TREAT model. Next, the energy deposition in TREAT is calculated: 181.05 ± 0.01 MeV for the “instantaneous” energy deposition (which accounts for the energy deposited within 1 s after neutron emission) in fuel and 189.90 ± 0.01 MeV for the total energy deposition in fuel. We discuss these results in this paper with previous calculations and experimental evaluations. This work demonstrates ALFRED’s potential as a high-fidelity tool for computing the spatial and temporal energy deposition in TREAT paving the way for a better understanding of the energy coupling factors in TREAT.

73 - NUCLEAR PHYSICS AND RADIATION PHYSICS↗